RQ00203078
CAS No. 1254205-52-1
RQ00203078( RQ-00203078 | RQ 00203078 | RQ00203078 )
Catalog No. M11029 CAS No. 1254205-52-1
RQ-00203078 is a highly selective, potent and orally available TRPM8 antagonist (IC50 values are 5.3 and 8.3 nM for rat and human channels respectively).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 39 | In Stock |
|
| 10MG | 65 | In Stock |
|
| 25MG | 113 | In Stock |
|
| 50MG | 177 | In Stock |
|
| 100MG | 332 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRQ00203078
-
NoteResearch use only, not for human use.
-
Brief DescriptionRQ-00203078 is a highly selective, potent and orally available TRPM8 antagonist (IC50 values are 5.3 and 8.3 nM for rat and human channels respectively).
-
DescriptionRQ-00203078 is a highly selective, potent and orally available TRPM8 antagonist (IC50 values are 5.3 and 8.3 nM for rat and human channels respectively), exhibits >350-fold selectivity for TRPM8 over TRPV4, TRPV1 and TRPA1.
-
In Vitro——
-
In Vivo——
-
SynonymsRQ-00203078 | RQ 00203078 | RQ00203078
-
PathwayMembrane Transporter/Ion Channel
-
TargetTRP/TRPV Channel
-
RecptorTRPM8
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1254205-52-1
-
Formula Weight554.85
-
Molecular FormulaC21H13ClF6N2O5S
-
Purity>98% (HPLC)
-
SolubilityDMSO: 100 mM
-
SMILESO=C(O)C1=CC=C(S(=O)(N(C2=NC=C(C(F)(F)F)C=C2Cl)CC3=CC=C(OC(F)(F)F)C=C3)=O)C=C1
-
Chemical Name4-(N-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)-N-(4-(trifluoromethoxy)benzyl)sulfamoyl)benzoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Chaussade C, et al. Biochem J, 2007, 404(3), 449-58.
molnova catalog
related products
-
MDR-652
MDR-652 is a highly specific and efficacious agonist of nonpungent transient receptor potential vanilloid 1 (TRPV1) with Ki value of 11.4 nM and 23.8 nM for hTRPV1 and rTRPV1 respectively and EC50s for hTRPV1 and rTRPV1 are 5.05 and 93 nM respectively.
-
Berbamine
Berbamine and its derivatives are promising agents to suppress liver cancer growth by targeting CAMKII.
-
GSK1702934A
GSK1702934A, a selective TRPC3 agonist, modulates cardiac contractility and arrhythmogenesis through TRPC3 activation.
Cart
sales@molnova.com